| Peripheral biomarkers of major depression and antidepressant treatment response: current knowledge and future outlooks BS Gadad, MK Jha, A Czysz, JL Furman, TL Mayes, MP Emslie, ... Journal of affective disorders 233, 3-14, 2018 | 155 | 2018 |
| Reduced anti-inflammatory gut microbiota are associated with depression and anhedonia BL Mason, Q Li, A Minhajuddin, AH Czysz, LA Coughlin, SK Hussain, ... Journal of Affective Disorders 266, 394-401, 2020 | 91 | 2020 |
| Lateral diffusion of Gαs in the plasma membrane is decreased after chronic but not acute antidepressant treatment: role of lipid raft and non-raft membrane microdomains AH Czysz, JM Schappi, MM Rasenick Neuropsychopharmacology 40 (3), 766-773, 2015 | 51 | 2015 |
| G-protein signaling, lipid rafts and the possible sites of action for the antidepressant effects of n-3 polyunsaturated fatty acids AH Czysz, M Rasenick CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2013 | 44 | 2013 |
| Childhood maltreatment and impact on clinical features of major depression in adults GC Medeiros, WL Prueitt, A Minhajuddin, SS Patel, AH Czysz, JL Furman, ... Psychiatry research 293, 113412, 2020 | 36 | 2020 |
| Can targeted metabolomics predict depression recovery? Results from the CO-MED trial AH Czysz, C South, BS Gadad, E Arning, A Soyombo, T Bottiglieri, ... Translational psychiatry 9 (1), 11, 2019 | 31 | 2019 |
| Comprehensive phenotyping of depression disease trajectory and risk: Rationale and design of Texas Resilience Against Depression study (T-RAD) MH Trivedi, CRC Fatt, MK Jha, CM Cooper, JM Trombello, BL Mason, ... Journal of psychiatric research 122, 22-32, 2020 | 27 | 2020 |
| Positive and negative valence systems in major depression have distinct clinical features, response to antidepressants, and relationships with immunomarkers GC Medeiros, AJ Rush, M Jha, T Carmody, JL Furman, AH Czysz, ... Depression and anxiety 37 (8), 771-783, 2020 | 25 | 2020 |
| Adiponectin moderates antidepressant treatment outcome in the combining medications to enhance depression outcomes randomized clinical trial JL Furman, A Soyombo, AH Czysz, MK Jha, TJ Carmody, BL Mason, ... Personalized medicine in psychiatry 9, 1-7, 2018 | 18 | 2018 |
| Impact of the COVID-19 pandemic on adults with current and prior depression: initial findings from the longitudinal Texas RAD study AH Czysz, K Nandy, JL Hughes, A Minhajuddin, CRC Fatt, MH Trivedi Journal of affective disorders 294, 103-108, 2021 | 16 | 2021 |
| Differential effects of antidepressants escitalopram versus lithium on Gs alpha membrane relocalization RJ Donati, J Schappi, AH Czysz, A Jackson, MM Rasenick BMC neuroscience 16, 1-9, 2015 | 15 | 2015 |
| One-pot generation of a tris-cationic homobimetallic planar-chiral ruthenacycle JP Djukic, L Fetzer, A Czysz, W Iali, C Sirlin, M Pfeffer Organometallics 29 (7), 1675-1679, 2010 | 12 | 2010 |
| Impact of childhood maltreatment on outcomes of antidepressant medication in chronic and/or recurrent depression GC Medeiros, WL Prueitt, AJ Rush, A Minhajuddin, AH Czysz, SS Patel, ... Journal of affective disorders 291, 39-45, 2021 | 5 | 2021 |
| Fibroblast growth factor 21 (FGF21) is increased in MDD and interacts with body mass index (BMI) to affect depression trajectory BL Mason, A Minhajuddin, AH Czysz, MK Jha, BS Gadad, TL Mayes, ... Translational psychiatry 12 (1), 16, 2022 | 4 | 2022 |
| Comparison of inflammatory markers as moderators of depression outcomes: A CO-MED study AH Czysz, BL Mason, Q Li, C Chin-Fatt, A Minhajuddin, T Carmody, ... Journal of affective disorders 295, 1066-1071, 2021 | 4 | 2021 |
| Improvement in Depressive Symptoms With Zuranolone Treatment in Patients With Major Depressive Disorder With or Without Elevated Anxiety: Pooled Analysis From the MDD-201B … A Czysz, C Nemeroff, A Schatzberg, R Lasser, L Park, Y Toubouti, ... Neuropsychopharmacology 47 (SUPPL 1), 201-202, 2022 | 2 | 2022 |
| CO200 Early Remission Is Associated with Lower Risk of Relapse: Analysis of Major Depressive Disorder Using STAR* D A Chitnis, L O'Callaghan, E Suthoff, A Czysz, R Iovin, AKC Joyner, ... Value in Health 26 (6), S52-S53, 2023 | | 2023 |
| Impact of medical comorbidity in biomarker discovery for major depressive disorder A Czysz Psychiatric Annals 50 (6), 239-243, 2020 | | 2020 |
| Antidepressant Treatment Depalmitoylates Gsalpha and Removes it From Lipid Rafts: A Mechanistic Rationale for This Cellular Hallmark of Antidepressant Response A Czysz, S Erb, M Ao, M Rasenick NEUROPSYCHOPHARMACOLOGY 44 (SUPPL 1), 454-454, 2019 | | 2019 |
| Dynamic interactions between G proteins and plasma membrane nanodomains: Effects of antidepressants and PUFAs AH Czysz University of Illinois at Chicago, 2015 | | 2015 |
Madhukar TrivediUT Southwestern Medical SchoolDirección de correo verificada de utsouthwestern.edu
